Drug profile · INN
clemastine fumarate
TAVIST
clemastine fumarate (TAVIST) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — clemastine fumarate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
clemastine fumarate (TAVIST) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is clemastine fumarate?
clemastine fumarate (TAVIST) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for clemastine fumarate?
TAVIST is a marketed brand name for clemastine fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clemastine fumarate?
clemastine fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.